European Respiratory Society Guidelines on the use of nebulizers.
about
Is nebulized saline a placebo in COPD?Pseudomonas aeruginosa ventilator-associated pneumonia managementPrimary Ciliary Dyskinesia: An Update on Clinical Aspects, Genetics, Diagnosis, and Future Treatment StrategiesAsthma pressurised metered dose inhaler performance: propellant effect studies in delivery systems.Identification and validation of nebulized aerosol devices for sputum induction.Developing ways to evaluate in the laboratory how inhalation devices will be used by patients and care-givers: the need for clinically appropriate testing.Relative bioavailability of terbutaline to the lung following inhalation, using urinary excretionDetermination of the bioavailability of gentamicin to the lungs following inhalation from two jet nebulizers.A modified nebulization modality versus classical ultrasonic nebulization and oxygen-driven nebulization in facilitating airway clearance in patients with acute exacerbation of chronic obstructive pulmonary disease: a randomized controlled trialA Handling Study to Assess Use of the Respimat(®) Soft Mist™ Inhaler in Children Under 5 Years Old.Statement on home care for patients with respiratory disorders.Relative lung deposition of salbutamol following inhalation from a spacer and a Sidestream jet nebulizer following an acute exacerbation.Physiotherapy for cystic fibrosis in Australia and New Zealand: A clinical practice guidelineThe challenge of delivering therapeutic aerosols to asthma patientsInhaled steroid/tobacco smoke particle interactions: a new light on steroid resistance.Review of recombinant human deoxyribonuclease (rhDNase) in the management of patients with cystic fibrosis.In vitro characterization of the I-neb Adaptive Aerosol Delivery (AAD) system.The Saudi Guidelines for the Diagnosis and Management of COPD.Consensus summary of aerosolized antimicrobial agents: application of guideline criteria. Insights from the Society of Infectious Diseases Pharmacists.Guidelines for aerosol devices in infants, children and adults: which to choose, why and how to achieve effective aerosol therapy.Inhaled chemotherapy in lung cancer: future concept of nanomedicine.Improved laboratory test methods for orally inhaled products.Advances in airway clearance technologies for chronic obstructive pulmonary disease.Nebulizers for drug delivery to the lungs.Factors to consider when selecting a nebulizer for a new inhaled drug product development program.Industry guidance for the selection of a delivery system for the development of novel respiratory products.Optimising Inhaled Pharmacotherapy for Elderly Patients with Chronic Obstructive Pulmonary Disease: The Importance of Delivery Devices.In vitro/in vivo correlation and modeling of emitted dose and lung deposition of inhaled salbutamol from metered dose inhalers with different types of spacers in noninvasively ventilated patients.Aerosolized Delivery of Antifungal AgentsPhysicochemical compatibility of fluticasone-17- propionate nebulizer suspension with ipratropium and albuterol nebulizer solutions.Guiding Principles for the Use of Nebulized Long-Acting Beta2-Agonists in Patients with COPD: An Expert Panel Consensus.Efficacy and usability of a novel nebulizer targeting both upper and lower airways.Evaluation of a Nanodispersion Formulation Prepared through Microfluidic Reactors for Pulmonary Delivery of Budesonide Using Nebulizers.In-vitro characterisation of the nebulised dose during non-invasive ventilation.Development and characterization of phospholipid-stabilized submicron aqueous dispersions of coenzyme Q₁₀ presenting continuous vibrating-mesh nebulization performance.Compatibility and aerosol characteristics of formoterol fumarate mixed with other nebulizing solutions.Quality of life measurements and bronchodilator responsiveness in prescribing nebulizer therapy in COPD.Effect of nebulized arformoterol on airway function in COPD: results from two randomized trials.Role of nebulized glycopyrrolate in the treatment of chronic obstructive pulmonary disease.Absence of lung fibrosis after a single pulmonary delivery of lipid nanocapsules in rats.
P2860
Q24792097-AB8DEE1C-F954-4C79-AC4D-158646084F4BQ26768365-A9A86694-3AD7-4111-934A-9A0A04B5B1A7Q33780616-2FF34561-A121-4B5E-8DFE-DF823D750945Q33857402-EEABAC3F-E4F1-4A31-93F0-F1F453948854Q34026807-36C81C79-5B57-4093-9554-9FB4C1EC6D0CQ34265177-883821DA-4A70-4137-86B8-BC6FA5B5286CQ34830183-5B78F418-92B9-4910-A887-D52E7760C002Q35826967-631902BF-FF52-4CF8-93C2-F8AFC25634E2Q35909235-F5D309E5-303C-40CE-AD09-C0F055985C9AQ36148273-AEC91CB8-29F9-4613-8685-A94D75D54F5EQ36154887-D9E4FE89-54CD-48E1-83B7-7A41684EAC31Q36535962-944DC865-3589-4D78-93E9-BCD35F7B3FE8Q36824415-BBF9187B-C238-4434-BA0F-DD0E06BC8964Q37105708-BB7A99A5-19BA-4B2A-80D8-A101989E14FBQ37244948-2C62E6F0-2F96-4DB8-A963-730C31131653Q37307836-18553EC8-A3B2-46DE-AC28-02D3C452EF37Q37725928-045E72CE-B9F5-4641-BC8C-D54430322546Q37733309-8C968F8B-7FAE-4FA9-96EC-506F1BC6932AQ37760514-BB55E6AE-824E-491D-8BC1-C1241775DC61Q37920900-C0B346BA-F9EA-42C1-97EC-356A7512467CQ38012447-544F8193-84C1-42DF-8B2A-60A030E492EAQ38126940-CC91BDE2-05AC-448D-9CEB-BA540A445232Q38162256-C434F4E3-3A2E-46C8-A8DB-DB1A677E213BQ38298171-54496EC8-F3CD-41C5-B428-3EA28FEE95DEQ38373085-DD1994DB-2B2D-48EB-B182-B9CC327ED429Q38525610-555EBF19-FB46-40A9-A2CA-5AA2A88D95CFQ38842452-227A5C28-FD70-4F70-866D-CC07E4E5F394Q40274049-B4D2102E-464C-439D-B0E5-DB5B6ED5B39AQ40522508-72E7262A-15C1-4C26-BAC7-E0D7FFD8C938Q41268562-464E83EC-CFFA-4C46-B771-CDFC4E042D0AQ41441617-168E232F-CDC4-4C22-872E-03BF330036C7Q42368102-680BE525-5D65-42BC-A7E7-013C2E5C2796Q42919022-D02E2ADC-ADA7-4168-8431-E68D5E018B22Q42956118-108B87C1-2144-483A-8D8C-13660555F2B1Q44550726-9AAD656C-776E-4934-8321-172E3C3BB96CQ46138212-39023393-88FF-4099-9C0D-DC68C0DDCCECQ46731570-BBEF978A-B4D1-4143-83C6-616572D6842FQ46764754-B0E3F0D2-C1F0-4995-A54B-1F44D004C49AQ47102804-E7E3448F-D256-4C80-A9D8-15E3F515ED1DQ47148526-BCDB1564-27B9-4981-AE21-AC866A4AB05D
P2860
European Respiratory Society Guidelines on the use of nebulizers.
description
2001 nî lūn-bûn
@nan
2001 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
European Respiratory Society Guidelines on the use of nebulizers.
@ast
European Respiratory Society Guidelines on the use of nebulizers.
@en
European Respiratory Society Guidelines on the use of nebulizers.
@nl
type
label
European Respiratory Society Guidelines on the use of nebulizers.
@ast
European Respiratory Society Guidelines on the use of nebulizers.
@en
European Respiratory Society Guidelines on the use of nebulizers.
@nl
prefLabel
European Respiratory Society Guidelines on the use of nebulizers.
@ast
European Respiratory Society Guidelines on the use of nebulizers.
@en
European Respiratory Society Guidelines on the use of nebulizers.
@nl
P2093
P1476
European Respiratory Society Guidelines on the use of nebulizers.
@en
P2093
B R O'Driscoll
European Respiratory Society Task Force on the use of nebulizers
J H Dennis
L Lannefors
P304
P356
10.1183/09031936.01.00220001
P577
2001-07-01T00:00:00Z